Company intelligence / Profile preview

Abyrx

Stamford, Connecticut, United Statesabyrx.com ↗

Ownership: Private
Employees: ~28
Development stage: Commercial

Overview

Abyrx develops and commercializes advanced biomaterials and surgical therapeutic devices, with a focus on water-soluble, settable, resorbable hemostatic bone putties. Their products are used to control bleeding and support bone healing in a variety of surgical specialties. The company’s solutions are protected by over fifty issued or pending patents and are available for use in orthopedic, trauma, spine, sports medicine, cranial/maxillofacial, and cardiothoracic surgeries. Key products include the Montage settable resorbable hemostatic bone putty portfolio.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: DeviceBiomaterial-based therapy (e.g., hemostatic bone putty)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

MONTAGE

Commercial

Indications: Surgical hemostasis, Bone repair

Beyond the preview

Go deeper on Abyrx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abyrx.

Explore the full profile